ZNF180 Activators
ZNF180 utilize diverse cellular signaling pathways to influence its activity within cells. Forskolin, through its direct activation of adenylyl cyclase, elevates intracellular cAMP levels, which in turn activates protein kinase A (PKA). PKA can phosphorylate a range of substrates including transcription factors and co-regulatory proteins that interact with ZNF180, enhancing its role as a transcriptional regulator. Similarly, the cAMP analogs 8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) and Dibutyryl-cAMP (db-cAMP) also raise cAMP levels, leading to activation of PKA and subsequent modification of proteins that govern ZNF180's activation. Additionally, Isoproterenol, a β-adrenergic receptor agonist, also increases cAMP and PKA activity, triggering a cascade that can augment the activity of ZNF180. These agents collectively modulate ZNF180 by altering the phosphorylation state of proteins that interact with it, thereby affecting its ability to bind DNA and regulate gene expression.
ZNF180 through alternative pathways. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can also lead to phosphorylation of proteins within ZNF180's regulatory network. Ionomycin raises intracellular calcium levels, potentially activating calcium-dependent signaling mechanisms that intersect with ZNF180's pathways. Epidermal Growth Factor (EGF) binds to its receptor, triggering a signal transduction cascade that can influence transcriptional activity where ZNF180 is involved. Retinoic acid, by acting on nuclear receptors, can modulate gene expression, potentially affecting the functional activity of ZNF180. Sodium butyrate and Trichostatin A, both histone deacetylase inhibitors, relax chromatin structure, which may improve ZNF180's access to its DNA binding sites. Conversely, 5-Azacytidine acts to demethylate DNA, which could alter ZNF180's DNA binding affinity and activity. Spermidine, known for its role in chromatin remodeling, can also facilitate the exposure of ZNF180 binding sites, enabling it to more effectively engage with DNA. Collectively, these chemical activators modulate ZNF180 activity by altering the cellular environment and the state of DNA and associated proteins, thereby influencing ZNF180's function in gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate regulatory proteins involved in the same pathways as ZNF180, potentially enhancing ZNF180's role in DNA binding and gene regulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent signaling pathways that intersect with pathways involving ZNF180's functional role, thereby leading to its activation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates cAMP-dependent protein kinase A (PKA), which may phosphorylate proteins that regulate ZNF180's activity in gene expression. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as an agonist for β-adrenergic receptors, leading to cAMP production and PKA activation, which can enhance the activation of ZNF180 through phosphorylation of associated regulatory proteins. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Db-cAMP is a cell-permeable cAMP analog that activates PKA, potentially leading to phosphorylation of proteins that modulate ZNF180's activity in the nucleus. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on nuclear retinoic acid receptors, which can regulate gene expression and potentially enhance ZNF180's functional activity in transcriptional regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, which can lead to demethylation and activation of certain genes, potentially affecting ZNF180's binding to demethylated DNA regions and its activation. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine is known to facilitate chromatin remodeling, which could expose binding sites for ZNF180, thus activating its DNA-binding activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate inhibits histone deacetylases, leading to a more relaxed chromatin structure, potentially enhancing ZNF180's access to DNA and its subsequent activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor, which may increase accessibility of DNA for binding by ZNF180, thus promoting its activation in regulating gene expression. | ||||||